Infosys Invests in 4baseCare to Revolutionize Precision Oncology
Infosys Limited Announces Strategic Investment in 4baseCare Precision Health Private Limited
Infosys Limited is investing in 4baseCare Precision Health Private Limited, a Healthcare and Life Sciences startup at the forefront of Deep Tech innovation. This initiative is part of the Infosys Innovation Fund, designed to foster collaborations with AI and DeepTech startups to create cutting-edge solutions.
Investment Highlights
- Investment Amount: INR 8.3 Crores (approximately US$ 1.0 million).
- Investment Type: Series A Compulsory Convertible Preference Shares.
- Shareholding: A minority stake, capped at 20% of 4baseCare’s outstanding share capital.
- Completion Timeline: On or before December 31, 2024.
Strategic Goals and Anticipated Benefits
- Advancing Personalized Cancer Care: 4baseCare’s expertise in precision oncology leverages genomics and clinical data, aligning with Infosys’s vision to improve cancer treatment outcomes.
- Harnessing AI and Analytics: By integrating AI and analytics into cancer diagnostics, treatment, and drug development, 4baseCare enhances Infosys’s Healthcare and Life Sciences portfolio.
- Co-Creation of Innovative Solutions: The partnership aims to merge Infosys’s technological expertise with 4baseCare’s advanced solutions to develop next-generation healthcare offerings.
About 4baseCare
- Core Focus: Innovating precision oncology solutions through advanced genomics and digital health technologies.
- Flagship Product: Genomic panels enabling oncologists to prescribe highly targeted and effective therapies.
- Growth Plans: Headquartered in Bengaluru, India, 4baseCare is expanding its operations across Asia and the Middle East, enhancing its use of advanced analytics and AI to deliver data-driven treatment recommendations.
This strategic partnership underscores Infosys’s commitment to driving innovation in the healthcare sector by leveraging transformative technologies.